53 WWW.SPINELINE-DIGITAL.ORG SEPTEMBER · OCTOBER 2017 | SPINELINE
Image depicts a sample built with Tritanium Technology used for in vitro cell studies. The sample was designed to mimic a generic interbody cage with an open graft window. This is not an
1. PROJ 43909 | Tritanium technology claim support memo
2. RD0000053710 | Tritanium cell infiltration and attachment experiment
3. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005 Sep; 26( 27):5474-91
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense
medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before
using any Stryker product. The products depicted are CE marked according to the Medical Device Directive 93/42/EEC. Products may not be available in all markets because product availability is
subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.
Stryker or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Built to fuse, Stryker, Tritanium. All other trademarks are
trademarks of their respective owners or holders.
Normal human osteoblast cells were used for in-vitro cell studies. No correlation to human
clinical outcomes has been demonstrated or established.
- Osteoblasts - Tritanium In-Growth Technology
A coupon built with Tritanium In-Growth Technology demonstrated that
osteoblasts (bone cells) infiltrated, attached to and proliferated on
the porosity of the Tritanium technology2. The unique porous structure
is designed to create a favorable environment for cell attachment2, 3.
Stryker’s proprietary Tritanium In-Growth Technology, used to build the
Tritanium cages, was designed for bone in-growth, cell proliferation2 and
Designed to create a favorable
environment for cells2, 3
Tritanium In-Growth Technology1
To see the latest in Stryker’s proprietary Tritanium In-Growth Technology1, visit us at booth #500 at the
2017 NASS Annual Meeting, October 25 - 28th in Orlando, FL or visit www.stryker.com/builttofuse
Built to fuse™